Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.

 
Web www.patentalert.com

< Arginine silicate inositol complex and use thereof

> Ion detection methods, mass spectrometry analysis methods, and mass spectrometry instrument circuitry

> Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
~ 00540